Prevention of hepatitis B in China: Achievements and challenges

Chinese Medical Journal

Volumn 122, Issue 24, 2009, Pages 2925-2927

  Lu, Feng Min ^a   Zhuang, Hui ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Epidemiology; Hepatitis B; Hepatitis B virus; Prevention

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CHINA; COST EFFECTIVENESS ANALYSIS; HEPATITIS B; HUMAN; IMMUNIZATION; INFECTION PREVENTION; INFECTION RISK; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; RISK FACTOR; SEROPREVALENCE; VIRUS TRANSMISSION;

CHINA; HEPATITIS B; HEPATITIS B VACCINES; HUMANS;

EID: 74549151090     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2009.24.001     Document Type: Article

References (23)

1. The Ministry of Health of the People's Republic of China. Yearbook of Chinese Health Statistical Digest, 2009. Beijing: Publishing House of Peking Union Medical University; 2009: 235-236.
2. Zhou YH, Wu C, Zhuang H. Vaccination against hepatitis B: the Chinese experience. Chin Med J 2008; 121: 98-102.
3. Cui FQ, Wang XJ, Liang XF. Epidemiological analysis on reported hepatitis B under 15 years in China: the report from Chinese Center for Disease Control and Prevention. Chin J Vaccine Immun (Chin) 2006; 12: 6-8.
4. Liang XF, Bi SL, Yang WZ, Wang LD, Cui G, Cui FQ, et al. Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in China. J Infect Dis 2009; 200: 39-47.
5. Wang ST, Wong XZ. Report of 5 cases of post transfusion serum hepatitis. J Peking Univ (Health Sci) (Chin) 1960; 1: 63-66.
6. Shang G, Seed CR, Wang F, Nie DM, Albert F. Residual risk of transfusion-transmitted viral infections in Shenzhen, China, 2001 through 2004. Transfusion 2007; 47: 529-539.
7. Shi YH, Zhuang H. Occult HBV. Infect Dis Inf (Chin) 2005; 18: 97-99.
8. Chen CR, Yuan Q, Ge SX, Ou SH, Ni HY, Zhang YC, et al. Surveillance for occult HBV infection and HBsAg variants in blood donors. Chin J Virol (Chin) 2009; 25: 178-184.
9. Wu X, Zhuo C, Huang WJ, Qi ZB, Liang ZL, Li HM, et al. Sensitivity and specificity of 4 domestic ELISA kits for detection of hepatitis B virus markers. Chin J Epidemiol (Chin) 2008; 29: 915-918.
10. Hou JL, Liu ZH, Gu F. Epidemiology and prevention of hepatitis B virus infection. Int J Med Sci 2005; 2: 50-57.
11. Zhang HW, Yin JH, Li YT, Li CZ, Ren H, Gu CY, et al. Risk factors for acute hepatitis B and its progression to chronic hepatitis in Shanghai, China. Gut 2008; 57: 1713-1720.
12. Tao CM, Huang TY, Feng PF, Wu CH, Liu YC, Li HF, et al. A preliminary study on hepatitis B vaccine. Chin Med J 1978; 90: 101-110.
13. Buynak EB, Roehm RR, Tytell AA, Bertland AU, Lampson GP, Maurice R, et al. Vaccine against human hepatitis B. JAMA 1976; 235: 2832-2834.
14. Mo ZJ, Shen LP, Yang JY, Zhou KJ, Li YP, Wei ZL, et al. Study on the relationship between hepatitis B vaccination and sero-epidemiology of infective status of hepatitis B virus. Chin J Vaccine Immun (Chin) 2007; 13: 216-218.
15. Tian C, Ma JC, Han CZ, Qi SX, Hao ZY, Zhuang ZY, et al. Infective status of HBV among population after 19 years immunization vaccine. Chin J Vaccine Immun (Chin) 2007; 13: 4-7.
16. Liang ZL, Li HM. A study on the cost-effectiveness of hepatitis B vaccine immunization on different populations in China. Chin J Biol (Chin) 2006; 19: 434-436.
17. Chen YS, Liang XF, Chen LJ, He X, Wang J, Wang XJ, et al. Sero-epidemiological study on hepatitis B in Chinese children. Chin J Vaccine Immun (Chin) 2006; 12: 84-87.
18. Gong J, Li RC, Yang JY, Li YP, Chen XR, Xu ZY, et al. Long-term of hepatitis B immunization program. Chin J Hepatol (Chin) 2003; 11: 203-205.
19. Dang RB, Zhang SX, Zhang WD, Liang XF, Cui FQ, Zhao F, et al. Assessment for immune effectiveness of hepatitis B vaccination among infant population in China. Chin J Public Health (Chin) 2009; 25: 385-387.
20. Li RC, Yang JY, Gong J, Huang ZN, Fang KX, Xu ZY, et al. Efficacy of hepatitis B vaccination for prevention of hepatocellular carcinoma in an endemic area of China. Chin J Hepatol (Chin) 2004; 25: 385-387.
21. Liang ZL, Li HM, Zhuang H. Studies on the influence factors on hepatitis B vaccine immune efficacy and strategy of enhancing inoculation. Chin J Epidemiol (Chin) 2007; 28: 313-314.
22. Zhuang H. Enhancement hepatitis B vaccination among no neonatal high risk population. Chin J Epidemiol (Chin) 2004; 25: 374-375.
23. Lu FM, Zhuang H. Management of hepatitis B in China. Chin Med J 2009; 122: 3-4.